|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300074658 |
|
最近更新日期: Date of Last Refreshed on: |
2023-08-11 15:22:08 |
|
注册时间: Date of Registration: |
2023-08-11 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
在弹力护具保护下的PNF治疗技术针对农村基层医院脊髓损伤患者的临床应用 |
|
Public title: |
PNF therapy under the protection of elastic protective gear for spinal cord injury patients in rural primary hospitals: a randomized controlled trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
在弹力护具保护下的PNF治疗技术针对农村基层医院脊髓损伤患者的临床应用 |
|
Scientific title: |
PNF therapy under the protection of elastic protective gear for spinal cord injury patients in rural primary hospitals: a randomized controlled trial |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王志婕 |
研究负责人: |
高潇 |
|
Applicant: |
Wang Zhijie |
Study leader: |
Xiao Gao |
|
申请注册联系人电话: Applicant telephone: |
+86 136 2347 1342 |
研究负责人电话:
Study leader's |
+86 139 4505 6365 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wang15244616809@126.com |
研究负责人电子邮件: Study leader's E-mail: |
gaoxiaohlj@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
山西省太原市并州西街46号 |
研究负责人通讯地址: |
黑龙江哈尔滨市果戈里大街411号 |
|
Applicant address: |
46 Bingzhou Street West, Taiyuan, Shanxi |
Study leader's address: |
No.411 Guogeli Street, Harbin, Heilongjiang |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
山西省中医院 |
||
|
Applicant's institution: |
Shanxi Provincial Hospital of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
黑龙江中医药大学附属第二医院 |
||
|
Affiliation of the Leader: |
the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
中医大二院伦[2023]K239号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
黑龙江中医药大学附属第二医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-06-07 00:00:00 | ||
|
伦理委员会联系人: |
逄静 |
||
|
Contact Name of the ethic committee: |
Jing Pang |
||
|
伦理委员会联系地址: |
黑龙江省哈尔滨市果戈里大街411号 |
||
|
Contact Address of the ethic committee: |
No.411 Guogeli Street, Harbin, Heilongjiang |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 187 0466 2557 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
黑龙江中医药大学附属第二医院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
the Second Affiliated Hospital of Heilongjiang University of Chinese Medicine |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
黑龙江省哈尔滨市果戈里大街411号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
No.411 Guogeli Street, Harbin, Heilongjiang |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
黑龙江省博士后科研启动金 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Postdoctoral Scientific Research Developmental Fund of Heilongjiang Province (LBH-Q21180) |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
脊髓损伤 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
spinal cord injury |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
对弹力护具保护下的PNF治疗技术针对农村基层医院脊髓损伤患者的临床应用疗效观察,探讨其对患者运动功能恢复程度的近期及远期改善情况,同时观察其不良反应发生情况。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
To observe the clinical efficacy of PNF treatment technology under the protection of elastic protective gear for spinal cord injury patients in rural primary hospitals, explore the short-term and long-term improvement of the motor function recovery degree of patients, and observe the occurrence of adverse reactions. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
1.满足脊髓损伤分级标准,所有患者均为完全性SCI(A)级; 2.双下肢肌张力≥2级; 3.无明显呼吸及心血管系统并发症; 4.脊柱稳定性良好; 5.自愿参加本研究,并同意签写知情同意书。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
1. The grading criteria for spinal cord injury were met, and all patients were in grade A of complete SCI; 2. Muscle tone of both lower limbs ≥2 level; 3. No significant respiratory and cardiovascular complications; 4. Good spinal stability; 5. Voluntarily participate in this study and agree to sign the informed consent form. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1.严重精神障碍、认知功能障碍、意识不清、言语功能障碍者; 2.有严重也肺或肝肾等多脏器疾病,合并生命体征不稳定者; 3.对器具治疗不能耐受患者; 4.因各种原因不接受随访者。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1. Severe mental disorder, cognitive dysfunction, confusion, speech dysfunction; 2. Patients with severe diseases of multiple organs such as lung, liver and kidney, combined with unstable vital signs; 3. Patients who cannot tolerate appliance treatment; 4. Not accepting interviewers for various reasons. |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-07-01 00:00:00至 To 2025-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-09-01 00:00:00 至 To 2024-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用SAS 9.3统计分析软件中的“Proc plan”程序生成随机序列。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The "Proc plan" program of SAS 9.3 statistical analysis software was used to generate the randomized sequence. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not shared |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集和管理由两部分组成,一为病例记录表,二为电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
A standard data collection and management system include a CRF and an electronic data capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |